Skip to main content

Table 2 Characteristics and knowledge of VHVs in six provinces of Laos, 2007

From: An assessment of early diagnosis and treatment of malaria by village health volunteers in the Lao PDR

  Non pilot area
n = 18 (%)
Pilot area
n = 18 (%)
p Total
n = 36
Sex (female) 0 (0) 3 (16.67) 0.07 3 (8.33)
Age (years)* 34.66 (28.71-40.61) 38.22 (33.75-42.68) 0.3 36.44 (32.86-40.02)
Training on RDT* (days) 2.61 (1.99-3.22) 2.72 (2.07-2.92) 0.7 2.55 (2.19-2.91)
Number of training 1.55 (1.20-1.90) 3.33 (2.15-4.51) 0.004 2.44 (1.78-3.10)
Main indications of MRDT**     
-Fever 16 (88.89) 18 (100) 0.1 34 (94.44)
-Headache 14 (77.78) 10 (55.56) 0.1 24 (66.67)
-Chills 13 (72.22) 7 (38.89) 0.04 20 (55.56)
No drug shop in village 12 (66.67) 17 (94.44) 0.03 29 (80.56)
Use village's kit** 15 (66.67) 15 (83.33) 0.2 27 (75)
Received ACT since (month)* 5.94 (4.30-7.58) 8.05 (7.09-9.01) 0.02 7 (6.02-7.97)
ACT shortage**** 7 (38.89) 10 (55.56) 0.31 17 (47.22)
Treatment for uncomplicated malaria μ     
-Chloroquine 14 (77.78) 4 (22.22) 0.004 18 (50.0)
-Coartem® 3 (16.67) 7 (38.89) 0.13 10 (27.78)
-Paracetamol 0 (0) 6 (33.33) 0.07 6 (16.67)
-Quinine 1 (5.56) 1 (5.56) 1 2 (5.56)
Knows where to get ACT 0 0   0
Cannot describe severe malariaμμ 11 (61.11) 5(50) 0.5 16 (44%)
Ever diagnosed severe malaria 7 (38.89) 8 (44.44) 0.7 15 (41.67)
Treatment given for severe malaria (n = 15) 3 (42.85) 6 (75)   9 (60)
- Referral 2 (28.57) 6 (75) 0.07 8 (55.33)
- Antimalarial 3 (42.85) 2 (25) 0.4 5 (33.33)
-Artesunate 3 (42.86) 0 0.03 3 (20)
-Quinine μμμ 0 (0) 2 (25.5) 0.3 1 (6.67)
-Dextrose infusion alone 1 (14.28) 3 (37.5) 0.3 4 (26.67)
  1. Non pilot areas: Luang Namtha. Savannakhet. Champasak.
  2. Pilot areas: Sekong. Saravan. Attapeu.
  3. *Mean and 95% IC = Interval confidence
  4. ** reported by VHVs
  5. *** 73% of the VHVs will give chloroquine.
  6. **** occurring since the initial provision of ACT and the survey
  7. μ Similar treatment options for suspected malaria (21 (58%) chloroquine; 9 (25%) Coartem®. 2 (6%) quinine; two associate chloroquine with Coartem® or quinine).
  8. μμμ one received quinine + doxycycline